1. Regorafenib Attenuates Osteoclasts Differentiation by Inhibiting the NF-κB, NFAT, ERK, and p38 Signaling Pathways
   Lin Zhou et al, 2024, ACS Omega CrossRef
2. Effects of Tyrosine Kinase Inhibitors on Growth and Bone Metabolism in Children with Haematologic Malignancies
   Athanasios Tragiannidis et al, 2022, Cardiovascular & Hematological Agents in Medicinal Chemistry CrossRef
3. Bevacizumab and sunitinib mediate osteogenic and pro-inflammatory molecular changes in primary human alveolar osteoblasts in vitro
   Elena Hofmann et al, 2022, Odontology CrossRef